Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-01-27

Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Tapentadol (CG5503) in the Treatment of Acute Pain After Abdominal Hysterectomy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating tapentadol for acute postoperative pain after abdominal hysterectomy has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tapentadol (Tapentadol hydrochloride)

Snippet

Sponsor: Grünenthal GmbH | Conditions: Hysterectomy, Postoperative | Phase 3 | Status: COMPLETED | Results posted: 2010-01-27